Showing results (501-510 of 549) with videos related to
Sort By:
Pageof 55
Journal of the International AIDS Society|January 5, 2023
Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settingsCaitlin M Dugdale, Ogochukwu Ufio, Christopher Alba, et al.Open Forum Infectious Diseases|January 14, 2022
Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South AfricaTijana Stanic, Nicole McCann, Martina Penazzato, et al.Journal of Medical Ethics|August 21, 2013
Consensus standards for introductory e-learning courses in human participants research ethicsJohn R Williams, Dominique Sprumont, Marie Hirtle, et al.BMJ Open|June 29, 2022
Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER)Emma Kalk, Alexa Heekes, Amy L Slogrove, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2023
Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence MonitorsLauren Jennings, Christopher M Ferraris, Jose R Castillo-Mancilla, et al.The Pediatric Infectious Disease Journal|July 17, 2025
The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2)Lisa Hagens, Lisanne A H Bevers, Thokozile R Malaba, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 26, 2025
Gluteal adipose tissue mitochondrial respiration and insulin sensitivity in pregnant South African women living with HIV on Tenofovir-Lamivudine-DolutegravirHlengiwe P Madlala, Jennifer Jao, Georgia Roussos, et al.The Lancet. Child & Adolescent Health|November 23, 2020
Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trialKatherine Gill, Leigh Johnson, Janan Dietrich, et al.Plos One|August 19, 2024
An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocolElaine J Abrams, Jennifer Jao, Hlengiwe P Madlala, et al.AIDS (London, England)|July 29, 2021
Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposedKim Anderson, Emma Kalk, Hlengiwe P Madlala, et al.Pageof 55